Skip to content

Svenningsson lab

Translational Research on Neuropharmacology and Movement Disorders

  • Home
  • News
  • Research
    • Pre-Clinical
      • P11 and G protein-coupled receptor function & pharmacology
      • Proteinopathies
    • Clinical
      • Clinical trials and Biomarkers in Parkinsonism
      • Ataxia, spastic paraparesis, chorea and other movement disorders
      • The role of glycemic control in Parkinson’s disease
  • Publications
  • People
    • Core Pre-Clinical Group
    • Core Clinical Group
    • Join our team
    • Alumni
    • Lab Group photos
  • Funding
  • Outreach
  • För Patienter
  • Contact

Tag: Parkinson's Disease

Posted on 7 July 2021

Funding from Nordtjernan Holding AB and the Axel Johnson Group

Professor Per Svenningsson from Karolinska Institutet receives funding for a five-year research project of SEK 38 million from Nordstjernan Holding AB and the Axel Johnson Group.

Read KI press release

Posted on 1 June 20217 July 2021

Wallenberg Clinical Scholars prolongation grant

Per Svenningsson was granted an extended Wallenberg Clinical Scholars grant for another five years.

See announcement here

Info about the Wallenberg Foundations on KI webpage

Posted on 3 March 20207 July 2021

Grant from the Swedish Research Council for medical research

The Svenningsson lab was awarded a grant from the Swedish Research Council, to study Receptor-mediating mechanisms in Parkinson’s disease and depression.

Read KI’s press release here

Postal Address

Karolinska Institutet
NKS, Bioclinicum
Visionsgatan 4
J5:20 Neuro- Svenningsson
Solna, 171 64

Telephone

+46 851774614

Our Karolinska Institute webpage

https://ki.se/en/cns/per-svenningssons-research-group-0

 

Proudly powered by WordPress